Calix Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag

Calix (ASX:CXL) Full Year 2025 Results

Key Financial Results

• Revenue: AU$28.2m (up 17% from FY 2024).
• Net loss: AU$19.2m (loss narrowed by 24% from FY 2024).
• AU$0.096 loss per share (improved from AU$0.14 loss in FY 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Calix EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) exceeded analyst estimates by 23%.

Looking ahead, revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 7.5% growth forecast for the Chemicals industry in Australia.

Performance of the Australian Chemicals industry.

The company's shares are down 13% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Calix has 6 warning signs (and 2 which are significant) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.